Reporter brief
Clinical Evaluation of mTORC1 Inhibition for Geroprotection
What happened
Trial registry update: COMPLETED. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- The abstract does not report actual results, outcomes, or whether the intervention was safe or effective—only the study design and planned protocol
- No effect sizes or sample sizes are provided, making it impossible to assess statistical power or the magnitude of any effects
- Comparison to the younger non-treated group does not constitute a control arm for the primary intervention question
Study design and sample
Rct; Human.
Participants aged 55-80 years old who are insulin resistant or prediabetic (intervention group); Participants aged 18-35 (non-intervention control group)
- Design
- Rct
- Sample
- —
- Journal
- University of Wisconsin, Madison
- Published
- Sep 4, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Rapamycin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.